Long-term Outcomes of Boston Type I Keratoprosthesis, and Efficacy of Amphotericin B and Povidone-Iodine in Infection Prophylaxis
Open Access
- 1 December 2021
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 232, 40-48
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Retention of the Boston Keratoprosthesis Type 1: Multicenter Study ResultsOphthalmology, 2013
- Microbiota Evaluation of Patients With a Boston Type I Keratoprosthesis Treated With Topical 0.5% Moxifloxacin and 5% Povidone–IodineCornea, 2013
- Boston type 1 keratoprosthesis outcomes in ocular burnsActa Ophthalmologica, 2013
- Risk Factors for the Development of Retroprosthetic Membranes with Boston Keratoprosthesis Type 1Ophthalmology, 2012
- Infectious Endophthalmitis After Boston Type 1 Keratoprosthesis ImplantationCornea, 2012
- Boston type 1 keratoprosthesis: the New York Eye and Ear experienceEye, 2011
- Longer-Term Vision Outcomes and Complications with the Boston Type 1 Keratoprosthesis at the University of California, DavisOphthalmology, 2011
- Evaluation and management of glaucoma after keratoprosthesisCurrent Opinion in Ophthalmology, 2011
- Successful Prevention of Bacterial Endophthalmitis in Eyes with the Boston KeratoprosthesisCornea, 2009
- Glaucoma associated with keratoprosthesis11The authors have no propriety interest in the devices used in this study.Ophthalmology, 1998